MRNA: My first Love

16 de jul.

MRNA is poised for a comeback. This is the first stock i ever bought and invested in, its one of the reasons why i started trading, and im glad to introduce it back into my investment portfolio.

Healthcare is recession proof, it can act as a great hedge against big tech, it can be used for diversification, it can benefit as we start a rotation transition, the company has a lot of potential outside COVID with its mRNA technology, and the technicals just look great!

First target 40% upside to 170$ before EOY.

Good luck!

18 de jul.

Comentário

Bought more on todays dip.

Good read 👇

tradingview.com/news/zacks:ec8373e6f094b:0-moderna-mrna-stock-rises-22-ytd-time-to-buy-the-stock/

28 de jul.

Comentário

MRNA is in a really great spot from a technical perspective and for a relatively young company, i think they are making import scale up moves that will help in the long-term 👇

tradingview.com/news/DJN_SN20240723008560:0/

It sucks to see highly esteemed scientist Bob Langer retire from the board but after looking into David Rubenstein's resume, i think he can really help scale up Moderna with his multitude experience in VC, politics and business and well sometimes you just need that for a company to grow 🤷

We are holding a multitude of key areas here on the daily chart and we have performed well for the past couple earnings along with being well below the 144$ average price tag by analysts. Playing earnings is always very risky so I'm sticking to shares only in my investment portfolio but i do think the upside potential far outweighs the downside here.



Only 4 more days, let's hope for a good one. 😎

2 de ago.

Comentário

WOW, what a sell off. This one is disappointing, the technical showed so much potential but sometimes the trades we plan out just don't play out how we want them too. Moderna actually reported decent revenue numbers but the past isnt as important as the future when it comes to earnings and the forwards guidance was poor. Its clear the COVID sales are slowing and they have forecasted lower sales in 2024 and as a result we have dumped over 21% on the day. YIKES! 😭

The technicals have been violated and the fundamentals point towards a slower year. The trade is no longer valid.



I am however still a Longterm believer in Moderna as i am a firm believer in the mRNA techology and have hope in the progress we are making.

"During the second quarter, we marked the approval of our second mRNA product and significantly lowered our operating costs," Chief Executive Stephane Bancel said in a statement. "We remain focused on execution for the 2024-25 COVID season and the launch of our (respiratory syncytial virus) vaccine in the US."

And i am I am especially interested in seeing how David Rubenstein can help scale the company. we went from 45 B to a 36B market cap and honestly i think cause the markets are weak it was a bit of an overreaction. We got flu season coming in during the second half of the year and i think once we bottom out we can slowly make our way up again to 115$.

7 de ago.

Comentário

alright so interesting day today. looked like we were ready to bounce and saw some green but closed red instead. The markets look weak and further downside is likely to come. The daily chart is looking oversold to me and i think we are due for a bounce soon 😤



i think if we can hold this area we can deadcat and fill the gap left around 92.50$, i will consider a option position to capture this move



after such i expect us to drop down to 72$ and start bottoming out at which point i will short MRNA



i will gladly buy shares at our lower support

12 de ago.

Comentário

establishing a base here, this looks ready to bounce

15 de ago.

Comentário

holding this area of consolidation here

17 de ago.

Comentário

NIce little bounce expect us to fill in gap here

20 de ago.

Comentário

we called the bounce, love to see it ! would like to see that gap fill for another 4.3%

28 de ago.

Comentário

upper gap failed to fill and as expected a dead cat has manifested, expect price to drop as low as 70$

2 de set.

Comentário

expecting price to continue to drop and level out

4 de set.

Comentário

NICE! 1st target hit, would like to see the lower gap fill and price touch the 70$ mark

9 de set.

Comentário

would like to see that gap fill

11 de set.

Comentário

no gap fill, looking to retest that previous support turned resistance.

13 de set.

Comentário

That was brutal! We filled hat 70$ gap we were hoping for at the news of MRNA cutting costs on R&D. I believe this is the low and have picked up a few shares

14 de set.

Comentário

Lots of fear surrounding this stock. And i dont blame them MRNA definitely isnt looking good in the near term. But I'm a Longterm believer in the mRNA platform and trust the team can turn it around. I want to see what David Rubenstein can do ! This company is a gem in my eyes

16 de set.

Comentário

nice little hold here, let see if we can shake off the FOMC news volatility, its a very important week for the market and good news is good for us here at MRNA



As i mentioned in the last post, this area is key for me and want to se us hold and accumulate and eventually bounce to retest the previous support now resistance, price cut from Goldman Sachs today, but they have us at buy still.

16 de set.

Comentário

21 de set.

Comentário

red week, inching near that 52 W low

30 de set.

Comentário

first green week in a while, lets see if we can hold this area

5 de out.

Comentário

very rough week, we look oversold and i expect us to hold this area of suppport

há 6 dias

Comentário

price has been brutal, upcoming earnings will be critical for this stock in terms of the short term

há 3 horas

Comentário

earnings right around the corner and its a critical one. This stocks been beaten down hard but, in my opinion, a little too hard. Investors want to hear something good otherwise were likely to fall lower in the near-term. Expect us to hang around support till earnings days.